Progression-free survival of GB patients and overall survival of adult glioma patients with high SPRY4 levels were reduced in our R2 genomics analysis, whereas other studies revealed that high expression of SPRY4 is associated with better prognosis for GB patients [123]. Here, SPRY4 is linked to glioma.